Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Phentolamine Mesylate

    Client Email Product

    Phentolamine Mesylate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    10
    US DMFs Filed

    US DMFs Filed

    4
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    5
    API REF. PRICE (USD / KG)
    49,653

    API Market Place

    14
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    5
    Europe

    Europe

    0

    Canada

    Canada

    2
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    5
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    32
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    6

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    22
    REF STANDARD

    EDQM

    3

    USP

    1

    JP

    0

    Other Listed Suppliers

    3
    SERVICES

    0

    Full View ScreenFull Screen View
    First Patient In LYNX-2 Phase 3 For Phentolamine After Eye Surgery
    First Patient In LYNX-2 Phase 3 For Phentolamine After Eye Surgery

    https://www.globenewswire.com/news-release/2024/04/11/2861621/0/en/First-Patient-Enrolled-in-LYNX-2-Phase-3-Study-Evaluating-Phentolamine-Ophthalmic-Solution-0-75-PS-for-the-Treatment-of-Decreased-Visual-Acuity-Under-Low-Light-Conditions-Following.html

    GLOBENEWSWIRE
    11 Apr 2024
    Share Share
    Viatris launches RYZUMVl 0.75% in US
    Viatris launches RYZUMVl 0.75% in US

    https://www.indianpharmapost.com/news/viatris-launches-ryzumvl-075-in-us-15472

    INDIANPHARMAPOST
    02 Apr 2024
    Share Share
    Viatris and Ocuphire's dilation eye drop Ryzumvi wins FDA nod
    Viatris and Ocuphire's dilation eye drop Ryzumvi wins FDA nod

    https://www.fiercepharma.com/pharma/viatris-and-ocuphire-score-dilation-eye-drop-nod-quest-become-global-eye-care-leader

    Fraiser Kansteiner FIERCE PHARMA
    27 Sep 2023
    Share Share
    Enforcement Report - Week of January 18, 2023
    Enforcement Report - Week of January 18, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf

    FDA
    18 Jan 2023
    Share Share
    MD Pharmaceutical Supply, LLC Receives FDA Warning Letter
    MD Pharmaceutical Supply, LLC Receives FDA Warning Letter

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/md-pharmaceutical-supply-llc-637815-11222022

    FDA
    28 Dec 2022
    Share Share
    Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol NDA from FDA
    Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol NDA from FDA

    https://www.globenewswire.com/news-release/2022/09/12/2514001/0/en/Ocuphire-Pharma-Receives-PDFUA-Fee-Waiver-for-Nyxol-New-Drug-Application-from-FDA.html

    GLOBENEWSWIRE
    12 Sep 2022
    Share Share
    Enforcement Report - Week Of June 01, 2022
    Enforcement Report - Week Of June 01, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf

    FDA
    01 Jun 2022
    Share Share
    Enforcement Report - Week of March 23, 2022
    Enforcement Report - Week of March 23, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-23-2022-1648013269.pdf

    FDA
    23 Mar 2022
    Share Share
    Enforcement Report - Week of November 17, 2021
    Enforcement Report - Week of November 17, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf

    FDA
    17 Nov 2021
    Share Share
    Enforcement Report - Week of March 11, 2020
    Enforcement Report - Week of March 11, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-11-2020-1583989701.pdf

    FDA
    12 Mar 2020
    Share Share
    Enforcement Report - Week of January 22, 2020
    Enforcement Report - Week of January 22, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-22-2020-1579699881.pdf

    FDA
    22 Jan 2020
    Share Share
    Ocuphire Pharma Announces Completion of the First of Two Ph2b Trials for Nyxol®
    Ocuphire Pharma Announces Completion of the First of Two Ph2b Trials for Nyxol®

    https://www.businesswire.com/news/home/20190904005979/en

    BUSINESSWIRE
    03 Sep 2019
    Share Share
    Enforcement Report - Week of July 17, 2019
    Enforcement Report - Week of July 17, 2019

    FDA
    17 Jul 2019
    Share Share
    Enforcement Report - Week of June 19, 2019
    Enforcement Report - Week of June 19, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2019-1560925761.pdf

    FDA
    19 Jun 2019
    Share Share
    Enforcement Report - Week of May 8, 2019
    Enforcement Report - Week of May 8, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf

    FDA
    08 May 2019
    Share Share
    Enforcement Report - Week of November 7, 2018
    Enforcement Report - Week of November 7, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-November-7-2018-1541578996.pdf

    FDA
    07 Nov 2018
    Share Share
    Enforcement Report - Week of August 22, 2018
    Enforcement Report - Week of August 22, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf

    FDA
    22 Aug 2018
    Share Share
    Enforcement Report - Week of May 16, 2018
    Enforcement Report - Week of May 16, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf

    FDA
    16 May 2018
    Share Share
    Health Canada Recalls OraVerse Injection
    Health Canada Recalls OraVerse Injection

    https://www.pharmacompass.com/pdf/news/health-canada-recalls-oraverse-injection-1524894049.pdf

    HEALTH CANADA
    28 Apr 2018
    Share Share
    Enforcement Report - Week of January 17, 2018
    Enforcement Report - Week of January 17, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf

    FDA
    17 Jan 2018
    Share Share
    Precision's Generic Phentolamine mesylate Receives Approval In US
    Precision's Generic Phentolamine mesylate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207686

    FDA
    18 Jul 2017
    Share Share
    US FDA Enforcement report- 13/Apr/2016
    US FDA Enforcement report- 13/Apr/2016

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-13apr2016-1460549225.pdf

    FDA
    12 Apr 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search